---
title: Utility of PD-1, PD-L1, and IDO-1 Stains in Ocular Extranodal Marginal Zone
  Lymphoma (MZL) and Diffuse Large B-cell Lymphoma (DLBCL)
date: '2024-06-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38899518/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240621182520&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Extranodal marginal zone lymphoma (EMZL) is the most common subtype of
  ocular lymphomas. Diffuse large B-cell lymphoma (DLBCL) and EMZL with large-cell
  transformation present diagnostic challenges. Radiotherapy is the standard treatment
  for ocular lymphomas, but complications and relapse are common. Diagnostic utility
  in challenging cases, as well as treatment options using immune checkpoint inhibitors,
  are unclear in ocular lymphomas. We herein investigated the PD-1, PD-L1, and IDO1
  ...
disable_comments: true
---
Extranodal marginal zone lymphoma (EMZL) is the most common subtype of ocular lymphomas. Diffuse large B-cell lymphoma (DLBCL) and EMZL with large-cell transformation present diagnostic challenges. Radiotherapy is the standard treatment for ocular lymphomas, but complications and relapse are common. Diagnostic utility in challenging cases, as well as treatment options using immune checkpoint inhibitors, are unclear in ocular lymphomas. We herein investigated the PD-1, PD-L1, and IDO1 ...